Hundreds of structures of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase (RT) have been determined, but only one contains an RNA/DNA hybrid. Here we report three structures of HIV-1 RT complexed with a non-nucleotide RT inhibitor (NNRTI) and an RNA/DNA hybrid. In the presence of an NNRTI, the RNA/DNA structure differs from all prior nucleic acid-RT structures including the RNA/DNA hybrid. The enzyme structure also differs from all previous RT-DNA complexes. Thus, the hybrid has ready access to the RNase-H active site. These observations indicate that an RT-nucleic acid complex may adopt two structural states, one competent for DNA polymerization and the other for RNA degradation. RT mutations that confer drug resistance but are distant from the inhibitor-binding sites often map to the unique RT-hybrid interface that undergoes conformational changes between two catalytic states.
a r t i c l e s HIV-1 is a lentivirus and the etiological agent of AIDS, a global pandemic for more than three decades. In addition to its RNA-or DNA-dependent DNA polymerase functions, the viral RT contains an RNase-H activity, which hydrolyzes the RNA strand of an RNA/DNA hybrid 1, 2 . Three of the four HIV-1 encoded enzymatic activities (protease, integrase and DNA polymerase) have been successfully targeted by antiviral drugs, but no inhibitor of RNase H has advanced to clinical trials. The viral DNA polymerase has the largest number of US Food and Drug Administration-approved inhibitors for treatment of HIV infection, including nucleoside analogs (NRTIs) and NNRTIs 3, 4 . The success of these treatments has granted many HIV-infected individuals active and fulfilling lifestyles. However, drug resistance continues to pose a major challenge, and new viral and host targets for drug development are needed.
HIV-1 RT consists of two polypeptide chains (p66 and p51) with both the DNA polymerase and RNase-H activities residing in the p66 subunit 5, 6 . RT is essential for copying and removing the viral RNA genome to make double-stranded DNA (dsDNA) before integration into the host genome 7, 8 . The viral RNase H is homologous to cellular RNase H1 and contains four conserved carboxylates in its active site that coordinate the two Mg 2+ ions necessary for catalysis [9] [10] [11] . To date, the majority of RNase-H inhibitors target the Mg 2+ ions in the active site [11] [12] [13] [14] . Because the two-Mg 2+ -ion mechanism is used by all polymerases and many nucleases 15, 16 , these RNase-H inhibitors may suffer from a lack of specificity. However, viral RNase H differs from cellular RNases H1 in that it prefers a longer substrate (>18 base pairs (bp)) and fails to cleave the polypurine-track (PPT) sequence in the viral genome, thus leaving the PPT intact to prime the second-DNA-strand synthesis [17] [18] [19] . Regions outside of the RNase-H domain must contribute to substrate binding in RT and are therefore potential targets for HIV-1 RNase-H inhibition.
A large number of HIV-1 RT structures have been reported, most of which are cocrystals of wild-type or mutant enzyme with NNRTIs 13, 14, [20] [21] [22] [23] [24] . There are more than 20 RT structures with ~20-bp nucleic acid substrates in binary or ternary complexes, representing the process of DNA synthesis or ATP-dependent excision of a chain terminator in the DNA polymerase active site [24] [25] [26] [27] [28] [29] . However, only one structure contains an RNA/DNA hybrid 30 . Unfortunately, none of the bound nucleic acid is captured in the RNase-H active site in a catalytic configuration. These structures of HIV-1 RT can be grouped into two general states, namely the 'closed' conformation when bound to a nucleic acid and the 'open' conformation with an NNRTI 2 .
Crystal structures of human and bacterial RNases H1 with an RNA/DNA hybrid in their active site have been determined 9, 10 . Although the two active sites of RT have been proposed to act simultaneously 19, 31 because the RNase H primarily cleaves the RNA template 18-19 bp from the primer 3′ end bound to the polymerase domain, the nucleic acids cocrystallized with HIV-1 RT in the polymerization mode, and the RNA/DNA hybrid in the RNase-H active site brought in by superposition of the cellular RNase H1-substrate complex cannot be connected 10 . Even with severe bending, an RNA/DNA hybrid cannot be modeled to engage both the DNA polymerase and RNase-H active sites 10 . Moreover, the anticooperativity of the two catalytic centers of RT and observations that NNRTIs can enhance the HIV-1 RNase-H activity [32] [33] [34] [35] [36] corroborate that DNA synthesis and RNA degradation occur sequentially on a single substrate. To determine how HIV-1 RNase H selects and binds its substrate and to open avenues for identifying new anti-HIV drug a r t i c l e s targets, we undertook structural analysis of HIV-1 RT complexed with non-PPT-containing RNA/DNA hybrids.
RESULTS
Three crystals of HIV-1 RT with RNA/DNA hybrids To favor binding of an RNA/DNA hybrid in the RNase-H active site, we inhibited RT polymerase activity by an NNRTI (nevirapine or efavirenz) and included a noninstructive abasic analog (tetrahydrofuran) at the templating position of the RNA strand (Fig. 1 ). To avoid RNase-H cleavage but preserve metal-ion and nucleic acid binding, we replaced the catalytic carboxylate Asp498 with alanine (D498A) or asparagine (D498N) 9, 10 . By varying the length of the RNA/DNA duplex and singlestrand overhang, we cocrystallized RT and the RNA/DNA hybrid in three different crystal lattices without chemical cross-linking or the necessity for a monoclonal antibody. A P3 1 21 crystal form diffracted X-rays to 3.3-Å resolution and contained wild-type RT, a nicked 22-bp hybrid and efavirenz (WT22efv) (Fig. 1a) . With nevirapine, R32 crystals containing D498N RT and a 25-bp hybrid (DN25nvp) and P6 1 22 crystals containing D498A RT and a 29-bp hybrid (DA29nvp) diffracted X-rays to 4.85-5.0 Å (Supplementary Fig. 1a,b) . These structures were determined and refined (Online Methods and Table 1 ). In all three cases, the electron density for RT and 21-22 bp of the RNA/DNA hybrids was unambiguous ( Fig. 1b and Supplementary Fig. 1c-e) . Efavirenz and nevirapine were also visible in the WT22efv and DN25nvp crystals ( Fig. 1b and Supplementary Fig. 1d ), but the density for nevirapine in the DA29nvp structure was nonexistent (Supplementary Fig. 1c) , probably owing to omission of the inhibitor in the crystal-stabilization buffer. These protein structures are essentially identical to each other but very different from those complexed with DNA (Fig. 1a,c) . As designed, the DNA polymerase active site is disengaged from catalysis. The p66 fingers subdomain is wide open and has few interactions with nucleic acid. The fingertip (residues 62-74), which interacts extensively with the template strand and an incoming nucleotide in the DNA synthesis mode, is disordered and not traceable here.
The RNA/DNA hybrids in the WT22efv and DN25nvp structures were similar in register relative to RT but differed from that of DA29nvp. In the first two crystals, we found that the 3′ end of the DNA reaches into the palm subdomain but is ~5 Å removed from the polymerase active site, and the RNA 5′ overhang exits over the fingers subdomain, as observed previously 26 (Fig. 1a,b and Supplementary  Fig. 1b ). These two complexes therefore correspond to the DNA 3′-directed mode, also known as the primary RNase-H cleavage 11, 19, 37 . In the DA29nvp crystals, exit of the hybrid from the RNase-H domain is blocked by a neighboring RT molecule (Supplementary Fig. 2a) , and the 29-bp hybrid most likely extended through the gap between the p66 fingers and thumb subdomains (Supplementary Fig. 1a) . The DA29nvp structure may thus correspond to the end-independent mode of RNase-H cleavage 11 .
The RNA/DNA hybrids in the WT22efv and DA29nvp crystals are both influenced by lattice contacts ( Supplementary  Fig. 2a,b) , and the RNA strand is displaced from the RNase-H active site by ~2 Å. The DN25nvp structure is suggestive of the potential chemistry of the RNase-H reaction (Supplementary Fig. 2c,d ), but the high-salt crystallization conditions and low resolution (5.0 Å) prevent unequivocal assignment of the active site configuration. The RNA/DNA hybrids in the three structures are overall in the A-form conformation and are similar but not identical. Perhaps because of a nick in the middle of the RNA strand in the WT22efv structure, the hybrid appears susceptible to deformation (Fig. 1d) . The half containing the 3′ end of DNA is superimposable with the hybrid in the 
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DA29nvp structure, and the other half is more similar to that in the DN25nvp structure. Nevertheless, the three RNA/DNA hybrids are much more similar to each other than to all structures of nucleic acids previously cocrystallized with RT ( Fig. 1) , and each bends by 20-30° when entering the RNase-H domain (13-14 bp from the DNA 3′ end; Fig. 1 and Supplementary Fig. 3 ). The following comparison uses the 3.3-Å WT22efv structure as a representative.
Two distinct RT conformations in nucleic acid complexes
In comparison to previously reported RT structures, the protein in our RT-hybrid complexes is more similar to those of RT-NNRTI complexes than RT-nucleic acid complexes (Fig. 2a-c and Supplementary Fig. 4) , thus removing the distinction between open apo and closed nucleic acid-bound conformations. We found that the open structure of RT stabilized by NNRTIs is fully capable of binding RNA/DNA hybrid. The presence of the RNA/DNA hybrid in addition to an NNRTI is coupled with an expansion of RT ( Fig. 2b and Supplementary Video 1) . The ~2.5-Å outward movement of the p66 fingers and RNase-H domain is necessary to accommodate the hybrid. Concomitantly, the p66 thumb subdomain tilts toward the duplex, and the p51 thumb moves with the RNase-H domain.
Structural changes are much more pronounced between our hybrid complexes and previously reported RT-nucleic acid complexes, for example, 1RTD 26 , 2HMI 38 , 1HYS 30 and 3KK2 (ref. 27) ( Fig. 2c and Supplementary Video 2). On the basis of difference-distance matrix analysis of each RT subunit ( Supplementary Fig. 4 ), the thumb, connection and RNase H domain of p66 did not change to any appreciable degree as compared to previously reported RT-nucleic acid complex structures (Supplementary Fig. 4b ). After superposition of these three domains, the p66 fingers and palm in our complexes appeared to open up with a clockwise screw movement relative to the C-terminal RNase H, as if to extend and unwind the hybrid (Fig. 2d) . Within the p51 subunit, the thumb underwent small movement relative to the other three subdomains (Supplementary Fig. 4b ). We found that the most pronounced changes occur at the p66 and p51 interface, and the two subunits are ~2 Å further apart in our hybrid complexes (Fig. 2c,d) .
Repacking of the two subunits has previously been observed when RT binds an NNRTI in the absence of nucleic acid substrate 20, 21, 39, 40 , but it is more obvious in our RT-NNRTI-hybrid complexes (Fig. 2c) . The changes at the p66-p51 interface are intimately linked to binding of the hybrid (details below).
Structural comparison with the recently reported RT-DNA-NNRTI complex 29 (PDB 3V81) turned out to be not as revealing. Perhaps owing to the cross-linking between RT and DNA and the procedure of soaking NNRTI into a preformed RT-DNA cocrystal, the protein structure of 3V81 is more similar to that of the RT-DNA-dNTP ternary complex than to that of either the RT-NNRTI complex or our WT22efv (Fig. 3a) . 
r t i c l e s
A hybrid structure compatible with cleavage by RNase H More than 20 structures of RT-nucleic acid complexes have been previously deposited in the Protein Data Bank, most of which were obtained after cross-linking the p66 thumb (through a Q258C substitution) to DNA (Fig. 1b) 26, 27, 29 . Only two structures of RT-nucleic acid complexes were obtained without the cross-link. One was cocrystallized with a monoclonal antibody bound to p51 (PDB 2HMI) 38 and the other with the PPT RNA/DNA hybrid (PDB 1HYS) 30 . The DNA structures in the previously reported RT-DNA complexes (with or without an incoming dNTP or even with an NNRTI 29 ) are nearly identical (Figs. 3b and 4a) . The only noticeable difference is that the DNA minor groove is slightly wider when containing the cross-link than when without it (Fig. 4a) . Unexpectedly, the PPT-containing RNA/DNA hybrid (1HYS) superimposes well with every dsDNA cocrystallized with RT and superimposes better with all cross-linked DNA structures than un-cross-linked structures (2HMI), despite the presence of 2′-OHs. The nucleic acid in our structures is considerably different from those reported previously and, more notably, from the PPT RNA/ DNA hybrid of 1HYS (Fig. 4b,c) . Although the sugar puckers in the previously reported PPT RNA/DNA structures were refined to have the A-like C3′-endo conformation, this hybrid duplex has a wide major groove and narrow minor groove with an average of 3.4-Å rise and 34.5° twist per base pair, values typical of a B-form conformation. In contrast, our hybrid structure is mostly in the A form, with a wide minor groove and narrow major groove (Supplementary Fig. 3 ). The hybrids in our structures have two kinks. In addition to the typical 20-30° bend adjacent to the p66 thumb 26 , the hybrid is also bent by 20-30° when entering the RNase H domain near helix αM (Fig. 1a,b) . Adjacent to this second bend, the RNA/DNA hybrid is underwound, which results in a widened major groove (Supplementary Fig. 3 ).
These changes in the hybrid (Fig. 4c) alter its position relative to the RNase-H domain in our complexes. Five years ago, to model an RNA/DNA in the RNase-H active site on the basis of the known RT-nucleic acid complex structures, the 3′ DNA end had to be relocated from the DNA polymerase catalytic center, and the hybrid was bent, in the middle, toward the p51 subunit 10 . The hybrid structures in our RT complexes, however, can be readily connected with the RNA/ DNA substrate cocrystallized with human RNase H1 after superposition of the homologous RNase-H domains ( Fig. 5 and Supplementary  Fig. 5 ). In the new structures, the DNA 3′ end is indeed not positioned for polymerization. Yet the most notable change was found in the middle of the 20-bp hybrid duplex, which is not as severely bent as proposed in order to place it for hydrolysis by the viral RNase H 10 but is underwound with a widened major groove (Supplementary  Video 3) . Both the underwinding and the 20-30° kink observed here may not be possible for the PPT, thus resulting in no cleavage of PPT by RT [17] [18] [19] . . 27) ). Upon superposition of the nucleic acids, both of which are cross-linked to p66 through Q258C, not only the DNAs are highly similar but also the RT proteins, except for the p66 fingers and palm subdomains, as indicated by the gray arrow. The protein and DNA are color coded as indicated, and the NNRTI (Nvp) is shown as purple spheres.
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The RT-RNA/DNA interface and drug-resistance mutations The large conformational changes in the p66 thumb and fingers subdomains upon binding to NNRTI or nucleic acid have attracted the most attention. Indeed, we found that in the WT22efv structure the presence of an NNRTI resulted in dramatic alterations of the p66 fingers (Fig. 2) . With the altered nucleic acid structure near the fingers and thumb (Fig. 4b,c) , the thumb (αH and αI) and the DNA polymerase 'primer grip' (β12-β13) in p66 maintained their contacts with the RNA/DNA, as observed in all previously reported RT-DNA complexes 25 . The structural changes that are coupled with the large conformational changes of the RNA/DNA hybrid and critical for RNA degradation, however, were found at the p51 and p66 subunit interface beyond the polymerase domain ( Supplementary  Videos 2 and 3) .
To accommodate the widened major groove of the RNA/DNA hybrid, two loops in p66, L18-K (the loop between β18 and αK, residues 356-364) and LB′-D′ (the loop between helices αB′ and αD′, residues 509-514) are reconfigured to avoid steric clashes (Fig. 6a) . To make these changes, an adjacent β turn (residues 333-336) that buttresses L18-K has two flexible glycine residues, Gly333 and Gly335. Of note, mutations that introduce larger and polar side chains (G333D, G333E, G335C or G335D) as well as A360I/V and Q509L nearby have been implicated in NRTI and NNRTI drug resistance with a concomitant reduction of RNase-H activity 41 (ref. 36 and references therein). These mutations may prevent the conformational change needed to accommodate the altered RNA/ DNA structure suitable for RNase-H cleavage and thereby favor the polymerization-competent state.
Adjacent to the widened major groove in our WT22efv structure, two areas of the altered p51-p66 subunit interface form new and substantial contacts with the minor groove of the hybrid (Fig. 6a) . The first area is between the two connection domains. Helix αL in p51 (residues 394-404) moves 1.5 Å, and helix αK in p66 (residues 364-384) moves 1.6 Å in the opposite direction (Fig. 6b) . As a result, Gln394 and Lys395 of p51 and Lys366 of p66 directly contact the DNA strand. Not surprisingly, mutations K366R, T369I, E399D and A400T have been implicated in NRTI and NNRTI resistance 36 . 
The second area is between helix αB′ in the RNase-H domain (residues 499-508) and the p51 C-terminal helix αM (residues 422-430), which also move apart in our hybrid complexes (Fig. 6c) . The extended segment comprising Phe416-Pro421, preceding αM, first interacts with the DNA strand and then crosses the shallow minor groove, where the hybrid is bent, to form van der Waals contacts with the RNA strand three nucleotides from the scissile phosphate (Fig. 6a,c) . The nearby tryptophan-repeat motif (residues 398-414) of p66 (ref. 42 ) concomitantly undergoes conformational changes (Fig. 6c) , thus resulting in DNA binding by Trp406 and Gln407. The altered p51 C-terminal structure is stabilized by a hydrogen bond formed between Tyr427 and Asn348 (Fig. 6c) . In previously reported RT-nucleic acid complexes, Asn348 is surrounded by hydrophobic side chains and has no close contacts. The N348I mutation, which has often been found to confer drug resistance to both NRTI and NNRTI, exhibits reduced RNase-H activity and altered cleavage patterns 36, 43, 44 .
The p51 C-terminal helix αM (residues 422-430) is relatively flexible and has been modeled as a random coil in earlier HIV-1 RT structures 26 or when the last 13-15 residues in p51 (440 in total) are truncated 24, 25 . In previously reported RT-nucleic acid complex structures, the p51 C-terminal residues are far removed from nucleic acid. The observation that deleting the C-terminal residues 427-440 of p51 alters RNase-H activity of HIV-1 RT 45, 46 was unexpected but can now be explained by the role of αM and residues preceding it in binding and orienting the nucleic acid substrate for RNA cleavage.
DISCUSSION
The three RT-RNA/DNA hybrid structures described here reveal substantial differences in protein and nucleic acid conformation from those reported previously. Although we cannot fully explain these alterations, inclusion of an NNRTI and the presence of an RNA/DNA hybrid without an artificial cross-linker are clearly contributing factors. These differences are consistent in the three different crystal forms, which differ in crystallization conditions, lattice contacts, hybrid lengths and NNRTI. It was observed previously that NNRTIs alter the p51-p66 interaction by both biochemical and structural methods 14, 20, 39, 40, 42 . It is notable that the p51-p66 interface is rather hydrophilic and somewhat porous ( Fig. 6 and Supplementary  Fig. 1e ). The fact that both NNRTI-induced conformational changes in the protein subunit interface and the presence of the RNA/DNA hybrid allow the nucleic acid to assume an orientation compatible with RNase-H cleavage suggests that the structures observed here are functionally relevant.
On the basis of observations that locking the nucleic acid substrate in the DNA polymerase active site reduces RNase H activity and that disengaging DNA polymerase activity with an NNRTI enhances the viral RNase H 33 , we proposed that two active sites of HIV-1 RT cannot simultaneously engage in catalysis 10 . A previous study suggested the opposite, on the basis of observations that when nucleic acid is stabilized or presumably 'locked' in the DNA polymerase active site, RNase-H activity is still measureable, albeit greatly reduced 31 . Residual RNase-H activity may, however, reflect transient dissociation of nucleic acid from the DNA polymerase active site rather than simultaneous catalysis. Analysis of concomitant polymerization and RNase-H activities 19 suggested that the two were coupled without substrate dissociation but did not exclude the sequential reactions.
The RT-RNA/DNA hybrid structures reported here support the proposal that the two active sites do not function simultaneously. Conformational flexibility in both the enzyme and RNA/DNA hybrid 47, 48 are required to switch a nucleic acid substrate between the two catalytic centers. For polymerization, the thumb, palm and fingers have the essential role of substrate alignment, as evidenced in all previous studies (Fig. 1b) . However, to orient an RNA/DNA hybrid for RNA degradation, the connection domains of both subunits and the p51 thumb are required (Figs. 1a and 6a) . NNRTIs inhibit polymerization by stabilizing the RT conformation incompatible for DNA synthesis, and NNRTI-resistance mutations often enhance the polymerization activity with a reduced RNase-H activity 23, 36 . Mutations that confer drug resistance in the connection domain, which is distal from the NRTI and NNRTI-binding sites, have to act indirectly on drug binding and were generally attributed to an allosteric effect in prior publications 35, 36 . Our RT-hybrid complex structures, however, show that the connection domains need to undergo conformational changes to orient the RNA/DNA and position the RNA strand for RNase-H cleavage. Drug-resistance mutations in general tip the balance of substrate partitioning between the two active sites in favor of DNA synthesis 36 , which can be achieved directly by altering the drug-binding sites (for example, Y181C, L74V or M184V) or allosterically by hindering the conformational changes in the connection domains (for example, G333D, T369I or N348I) necessary for RNA degradation.
In contrast to cellular enzymes, HIV-1 RNase H depends on the rest of RT to bind an RNA/DNA hybrid and has a strong cleavage preference ~18 nucleotides upstream from the end of a hybrid marked by a 3′ end of DNA or a 5′ end of RNA 19, 37, 49 . Within the ~1,000 Å 2 enzyme-substrate interface, the DNA polymerase and RNase-H active sites have been the primary target of anti-HIV drug development. Only recently, vinylogous ureas, which bind at the subunit interface and inhibit RNase-H activity, have been identified by high-throughput screening 46, 50, 51 . The structures reported here reveal substantial contributions from the thumb and connection domains from both RT subunits in RNA/DNA binding, thus providing an enlarged and underexplored target for future drug development.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Preparation of protein and nucleic acid substrates. Recombinant HIV-1 RT, a heterodimer of p66 and p51 subunits, was expressed in E. coli and purified as described previously 53 . D498N and D498A mutations were introduced into the RNase H domain, by using QuikChange Kit (Stratagene), to eliminate RNase-H activity. In addition, wild-type RT with a removable His 6 tag was constructed by inserting a PreScission cleavage site between the tag and the p51 N terminus. Briefly, His-tagged RT was purified by using immobilized metal-affinity and heparin-Sepharose chromatography. After removing the His 6 tag by overnight proteolysis at 4 °C in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA and 1 mM DTT, the protein solution was adjusted to 40 mM NaCl and loaded onto a MonoS column. The tag-free RT was eluted with a linear NaCl gradient of 40-250 mM. HPLC-purified RNA oligonucleotides were purchased from Dharmacon. DNA oligonucleotides (trityl-on) were purchased from the Facility for Biotechnology Resources at NIH and purified by using an R3 reverse-phase column before detritylation. Hybrid substrates were annealed at a 1:1 ratio by using a thermocycler, heating at 75 °C for 10 min and slow cooling to 20 °C at a rate of 1 °C/min.
Crystallization. Annealed RNA/DNA hybrids were mixed with HIV-1 RT and an NNRTI (Nevirapine or Efavirenz) at a 1.2:1:2 molar ratio in the buffer containing 10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM DTT, 0.1 mM EDTA and 5 mM MgCl 2 (for D498A/N mutant RT) or 5 mM CaCl 2 (for wild-type RT) and concentrated to ~15 mg/ml RT in the protein-nucleic acid complexes. Formation of a 1:1 complex of protein and hybrid substrate was confirmed by gel-filtration chromatography and PAGE (Supplementary Fig. 6 ). Crystals were grown by either the hanging-or sitting-drop vapor-diffusion method at 4 °C. Each complex, consisting of WT or mutant RT (Table 1) , an NNRTI ( Table 1) and an RNA/DNA hybrid ( Fig. 1 and Supplementary Fig. 1 Data collection, structure determination and refinement. X-ray diffraction data were collected at the beamline 22-ID, 22-BM and 23-IDB at the Advanced Photon Source, Argonne National Laboratory, Argonne, IL. Crystal forms in P3 1 21 (WT22efv), P6 1 22 (DA29nvp) and R32 (DN25nvp) diffracted to 3.3 Å, 4.8 Å and 5.0 Å, respectively. Data were indexed and scaled by using HKL2000 (ref. 54) or XDS 55 . Structures were solved by molecular replacement by using the RT from the ternary complex (1RTD) and RT with NNRTI (1FK9) 22, 26 with MolRep in CCP4 (ref. 56) . After placing the protein portion without any refinement, the density for RNA/DNA hybrid was clear in each case. All structures contained one heterodimeric HIV-1 RT and one RNA/DNA hybrid in each asymmetric unit.
Different refinement scenarios in PHENIX 57 were applied, depending on data resolution, including grouped (rigid body) and restrained coordinate refinement and restrained individual isotropic atomic displacement parameters refinement. Refinement was combined with bulk solvent correction and anisotropic scaling. Restraints on hydrogen bonds and planarity between base pairs of an RNA/DNA hybrid were custom-made and applied. Manual corrections were performed in COOT 58 . Data collection and refinement statistics are shown in Table 1 .
The WT22efv structure contains residues 4-556 of p66 (chain A) and residues 7-431 of p51 (chain B). Tracing of p66 is continuous except for the fingertip (residues 62-74), which is omitted due to the missing density in this region. Residues 216-230 in p51 are disordered. The RNA/DNA hybrid contains 24 out of 27 ribonucleotides and 22 out of 24 deoxynucleotides (Fig. 1a) . The NNRTI Efavirenz is included (Fig. 1b) . The protein has 95% residues in the favored regions in the Ramachandran plot. All seven outliers are associated with poorly defined electron densities. In the NA29nvp structure, 519 residues of p66, 404 residues of p51 and 21 bp of RNA/DNA hybrid are built ( Supplementary  Fig. 1a) . The protein has 94% residues in most preferred regions and 0.33% outliers in the Ramachandran plot. In the DN25nvp structure, 21 bp of RNA/DNA hybrid are traceable (Supplementary Fig. 1b) , and Nevirapine is included. The RT has 95% residues in most preferred regions with no outliers.
Because these structures were solved by molecular replacement, to verify the structural models we calculated simulated annealing omit maps by using Phenix.refine. Because the RNA/DNA consists of more than 10% of total diffraction matters, calculation of the simulated annealing of the entire hybrid was carried out in fragments to avoid distortion and was assembled into a composite map. For the WT22efv structures, DNA and RNA chains were split into three segments and simulated annealing F o -F c omit maps were calculated for each portion individually by setting the occupancy of the segment of nucleic acid to zero. The simulated annealing in Phenix.refine was run with the parameter of ignore_zero_occupancy_atoms = False, which prevented the solvent mask from extending into the nucleic acid chain region. The composite omit maps thus generated clearly show the density for DNA and RNA at 4σ (Fig. 1b) .
For low-resolution structures of DA29nvp and DN25nvp, a similar approach was applied for DNA/RNA. However, the hybrids had to be split into smaller regions (3 nucleotides per run) to calculate simulated annealing omit maps. The simulated annealing omit maps countered at 2.5σ (DA29nvp) and 3σ (DN25nvp) clearly show the unbiased DNA/RNA path ( Supplementary Fig. 1c,d ).
Structural analysis. Proteins were superimposed by using COOT 58 , and s.d. were computed by using ALIGN 59 . DDMP 60 was calculated by using the algorithm written by P. Fleming (Johns Hopkins University). The pairwise Cα movement is displayed by using ModeVector in PyMOL (http://www.PyMol.org/). Nucleic acid structures were analyzed by using 3-DNA 61 and Curve+ (http://gbio-pbil.ibcp. fr/cgi/Curves_plus/) 62 . All structural figures were prepared by using PyMOL.
